Oral Vitamin D3 Effect on Inflammatory Biomarkers in Ulcerative Colitis Patients

Recruiting now · Not applicable

Conditions studied: Ulcerative Colitis (UC)

In brief

This randomized controlled trial aims to evaluate the effect of oral vitamin D3 supplementation on inflammatory biomarkers and disease activity in Pakistani patients with moderate ulcerative colitis. Sixty patients will be randomized to receive either standard treatment alone/Placebo or standard treatment plus vitamin D3 (50,000 IU fortnightly) for 12 weeks. Primary outcomes include changes in blood (CRP, ESR, IL-6) and fecal (calprotectin) inflammatory biomarkers, and disease activity assessed by the partial Mayo score. Secondary outcomes include vitamin D status, dietary intake, and quality of life. The study will provide insights into the immune-modulating and anti-inflammatory role of vitamin D3 as an adjunct therapy in ulcerative colitis.

Key facts

Study ID

NCT07269223

Run by

University of Veterinary and Animal Sciences, Lahore - Pakistan

People needed

60

Starts

2025-09-02

Expected to finish

2025-12-30

Last updated by the study team

2025-12-17

Who can join

Age: 20 and older, up to 40. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• • All patients diagnosed previously by standard clinical i.e Truelove and Witts and endoscopic/ colonoscopic criteria
• Patients with moderate ulcerative colitis will be included
• Both male and female patients will be included in the study
• No change in the type and dosage of their medicine over the past month
• Patient with severe vitamin D deficiency (< 10 ng/mL) after screening
• Patients who will provide written informed consent
• Age: 20-40 year
• Exclusion Criteria:• Patients using Vitamin D supplement in the 3 months before the study
• Patients suffering from Crohn's disease or any known autoimmune disease
• Patients with mild and severe ulcerative colitis
• Changes in the type and dosage of the drug during the study
• Pregnant and lactating women
• Patients with known kidney disease
• Patients with known liver disease

Where it is running

• University of Veterinary & Animal Sciences, Lahore — Lahore, Punjab Province, Pakistan (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.